Table 2 Comparison of clinical data before 131I therapy between groups

Gender(M/F)

6/16

6/22

12/93

7/41

Age(y)

45.50±11.70

38.86±11.96

44.67±12.64

44.77±11.67

FT3(pmol/L)

21.18±8.86

25.05±6.35^*

18.87±9.05^*

22.18±8.38

FT4(pmol/L)

62.64±37.24

64.02±35.42

52.18±30.28

63.41±37.87

TSH(mIU/L)

0.06±0.25

0.004±0.003^#

0.06±0.36

0.01±0.017

TPOAb(IU/mL)

859.05±575.77

899.25±550.87

835.48±562.10

802.49±574.35

TRAb(IU/L)

15.76±12.15

15.18±12.55

16.97±12.11

18.48±13.00

¹³¹I dose(mCi)

8.14±2.32

9.59±2.86

8.74±3.53

7.84±2.86

24 h maximal ¹³¹I uptake rate(%)

73.89±9.55

68.91±10.09

72.24±12.92

75.85±12.42